Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 396 Cr.
- Current Price ₹ 322
- High / Low ₹ 351 / 162
- Stock P/E 68.5
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 15.7 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding has decreased over last quarter: -24.7%
- Company has a low return on equity of 13.9% over last 3 years.
- Company has high debtors of 193 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 89.29 | 70.23 | 113.70 | 124.67 | 97.39 | |
| 83.30 | 68.78 | 107.47 | 111.83 | 88.84 | |
| Operating Profit | 5.99 | 1.45 | 6.23 | 12.84 | 8.55 |
| OPM % | 6.71% | 2.06% | 5.48% | 10.30% | 8.78% |
| 0.78 | 0.26 | 0.25 | 0.44 | 0.60 | |
| Interest | 0.58 | 0.36 | 0.76 | 1.20 | 1.12 |
| Depreciation | 0.68 | 0.82 | 0.58 | 0.53 | 0.50 |
| Profit before tax | 5.51 | 0.53 | 5.14 | 11.55 | 7.53 |
| Tax % | 28.49% | -41.51% | 28.99% | 30.65% | 24.97% |
| 4.00 | 0.76 | 3.65 | 8.01 | 5.82 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.92 | 28.57 | 20.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 98% |
| TTM: | -27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 2.79 | 2.79 | 2.79 | 9.06 |
| Reserves | 30.88 | 31.63 | 34.79 | 42.75 | 48.86 | 53.00 |
| 10.24 | 7.14 | 8.50 | 5.66 | 5.75 | 3.20 | |
| 26.06 | 30.25 | 35.80 | 29.37 | 31.71 | 29.13 | |
| Total Liabilities | 67.21 | 69.05 | 81.88 | 80.57 | 89.11 | 94.39 |
| 4.20 | 4.70 | 4.38 | 4.07 | 5.11 | 4.99 | |
| CWIP | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
| Investments | 0.39 | 0.39 | 0.04 | 0.05 | 1.05 | 8.60 |
| 62.62 | 63.96 | 77.33 | 76.45 | 82.95 | 80.80 | |
| Total Assets | 67.21 | 69.05 | 81.88 | 80.57 | 89.11 | 94.39 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -8.68 | 3.88 | 2.73 | 7.98 | 2.76 | |
| 2.49 | -0.92 | -3.59 | -3.14 | -1.52 | |
| 7.40 | -3.38 | 0.74 | -3.96 | -0.94 | |
| Net Cash Flow | 1.21 | -0.42 | -0.12 | 0.87 | 0.31 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 181.05 | 221.19 | 165.29 | 143.72 | 193.39 |
| Inventory Days | 62.64 | 94.58 | 62.71 | 56.89 | 87.75 |
| Days Payable | 114.14 | 146.09 | 104.51 | 81.58 | 121.65 |
| Cash Conversion Cycle | 129.55 | 169.68 | 123.49 | 119.04 | 159.48 |
| Working Capital Days | 154.27 | 178.89 | 118.65 | 111.31 | 156.43 |
| ROCE % | 2.15% | 13.73% | 25.90% | 15.74% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16 Apr - Analyst/investor plant visit rescheduled to May 10, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Apr - Of Physical Plant visit for Investors and Analysts (Participants) on April 19, 2025, Saturday at Umbergaon, Gujarat.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Compliance certificate under SEBI regulations for Q1 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
4 Apr - Resignation of Company Secretary due to personal reasons.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
4 Apr - Resignation of Company Secretary due to personal reasons.
Annual reports
No data available.
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.